Tilray Earnings Give Aphria Shares A Bump

Tilray Earnings Give Aphria Shares A Bump

Investing.com  | Feb 23, 2021 05:25

Tilray (NASDAQ:TLRY) grabbed all the headlines last week after it posted its first profitable quarter—on an adjusted basis —last Wednesday. But by the end of the week, it was Aphria (NASDAQ:APHA) (TSX:APHA), the company it is set to merge with to form the world’s largest cannabis company, that walked away with all the gains.

Tilray Daily

Shares of Tilray saw an immediate lift after it unveiled its earnings last week that included US$50.7 million in net revenue, a huge gain compared with the same period last year. It also reported a substantial US$57-million drop in costs, a move that helped it to report an adjusted US$2.2-million profit for the three-month period, ahead of the 2021 Q2 close of its announced merger with Aphria.

The news sent Tilray shares up with double-digit gains. But by the end of the week, the stock was down about half a percentage point, closing Friday at $29.21, lower by just over 2% on the week. It dropped again yesterday, finishing the day down another 10% at $26.29.

Aphria Daily

Meanwhile Aphria stock closed last week with an almost 20% gain in its price. Shares of the Canadian cannabis grower spiked in mid-week last week on the strength of the Tilray headlines, to hit a high of $21.98 before closing of the week at $20.28. It has since given back some of those gains, closing yesterday at $19.35. Year to date, Aphria is up about 177%

Hexo Strikes Deal With Zenabis

Tilray is not the only major cannabis company that is on the path to becoming one of the biggest in a class.

Last week, Hexo Corp (NYSE:HEXO) (TSX:HEXO) announced it has struck a C$235 million (US$185.7 million) all-stock deal to acquire Zenabis Global (OTC:ZBISF) (TSX:ZENA), a Vancouver-based company that is among Canada’s largest licensed producers of medical and recreational cannabis. The new combined company will be among the “top three licensed producers in terms of combined Canadian recreational cannabis sales,” according to a joint statement issued by the companies.

The deal will increase Hexo’s greenhouse growing capacity and immediate access to the European medical cannabis market through Zenabis’s local partnership network.

Shares of Hexo have gained almost 43% in the past year.

Canadian Cannabis Sales Soar, But Fail To Meet Predictions

Canadian legal marijuana sales were way up in 2020, according to the latest figures released by Statistics Canada. But despite the bump, the figures are below what analysts had predicted.

In 2020, Canadians purchased C$2.6 billion (US$2.1 billion) of legal recreational cannabis, more than twice the amount purchased in 2019, according to the figures released by StatsCan last week. The exact jump amounted to a 120% increase in sales. Forecasters, however, claimed the market would grow to more than C$3 billion (US$2.37 billion), with analysts with BDS Analytics having said sales would hit C$3.3 billion (US2.6 billion), while Cowen & Co., according to media reports, were expecting to see sales hit C$3.5 billion (US$2.765 billion).

Despite analysts having missed the mark, at least one prediction for the current year expects to see the Canadian recreational weed market will hit the C$4-billion (US$3.16 billion) mark. That is the word from Stifel-GMP analyst Andrew Carter, as reported by BNN Bloomberg.

New Jersey Legalizes Pot

New Jersey became the 13th state to legalize cannabis on Monday after voters last November supported the move. New Jersey joins Maine, Vermont and Massachusetts as the only other states in the northeast US to legalize marijuana.

The bill that was signed into law also allows state-approved dispensaries to sell the substance, although it could take up to a year before sales of recreational cannabis will be seen.

Investing.com

Related Articles

Latest comments

Add a Comment
Please wait a minute before you try to comment again.
Discussion
Write a reply...
Please wait a minute before you try to comment again.

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

English (USA) English (UK) English (India) English (Australia) English (South Africa) English (Philippines) English (Nigeria) Deutsch Español (España) Español (México) Français Italiano Nederlands Português (Portugal) Polski Português (Brasil) Русский Türkçe ‏العربية‏ Ελληνικά Svenska Suomi עברית 日本語 한국어 简体中文 繁體中文 Bahasa Indonesia Bahasa Melayu ไทย Tiếng Việt हिंदी
Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes

+

Download the Investing.com App

Get free real time quotes, charts and alerts on stocks, indices, currencies, commodities and bonds. Get free top of the line technical analysis/predictors.

Investing.com is better on the App!

More content, faster quotes and charts, and a smoother experience is available only on the App.